Viewpoint CSO presents at the TWC in South Korea
August 9, 2019
March 2nd, 2019 – Jeju Island, South Korea, Viewpoint Chief Science Officer Michael Schultz, PhD delivered an invited presentation at the 5th Theranostics World Congress in Jeju, South Korea. The area of discussion was on the Next Generation Theranostics (from Chemists’ Point of View) – Alpha Emitters. Dr. Schultz spoke about 203Pb/212Pb Peptide Receptor Targeted Theranostics for Cancer.